PhRMA Urges Japan To Maintain Drug Prices Amid MFN Concerns

 
• By Lisa Takagi
  
Japan PhRMA
PhRMA restates concerns about Japan's drug reimbursement pricing practices (Shutterstock)

More from Pricing Debate

More from Japan